Brazil suspends clinical trials of Bharat Biotech's Covaxin

“The Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil,”Anvisa, the Brazilian health regulator said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news